611 W. Union Street
Benson, AZ 85602
(520) 586-0800

LaFrontera
member support line
1-520-279-5737
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530



SEABHS
611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line
1-866-495-6735

NAZCARE Warm Line
1-888-404-5530


powered by centersite dot net

Getting Started
Here are some forms to get started. These can be printed and brought with you so that you can pre-fill out some known info ahead of time. More...


Medical Disorders
Resources
Basic InformationLookupsLatest News
Low Vitamin D Levels Tied to Higher Odds for Severe COVIDKids Much Less Prone to Coronavirus Infection Than Adults: Study'Silent' COVID-19 Produces as Much Virus as in Patients With Symptoms: StudyImmune System Clues to Why COVID Is Easier on KidsU.S. Coronavirus Cases Top 7 MillionAccuracy of COVID-19 Antibody Tests Varies Widely, Study FindsAmerica's COVID Pandemic Is Now Skewing YoungerEven If Hips, Legs Slim Down, Belly Fat Remains a Health DangerAfter COVID-19 Exposure, When Can Young Athletes Resume Play?Kids Who Need Steroids Face Risk of Diabetes, Other Ills9 in 10 Americans Not Yet Immune to COVID, CDC Director SaysCommon Heart Defect Limits Exercise Ability: StudyBlood Test Could Spot Those at Highest Risk for Severe COVID-19Singing Without a Face Mask Can Spread COVID-19Could Zinc Help Fight COVID-19?U.S. COVID Death Toll Hits 200,000 as Cases Climb in 22 States4 Out of 5 People With COVID-19 Will Develop Symptoms: StudyMany Health Care Workers Who Have Coronavirus Don't Have Symptoms: StudyAHA News: Cluster of Risky Conditions That Can Lead To Heart Disease Is Rising in Hispanic AdultsMinorities Hit Hardest When COVID Strikes Nursing HomesAvoid the 'Twindemic:' Get Your Flu Shot NowCertain Cancer Treatments May Heighten Danger From COVID-19Homemade Masks Do a Great Job Blocking COVID-19Having Flu and COVID Doubles Death Risk in Hospitalized PatientsGuard Yourself Against the Health Dangers of Wildfire SmokeLife Expectancy Could Decline Worldwide Due to COVID-19Potential COVID-19 Drug Could Increase Heart Risk: StudyU.S. COVID Death Toll Nears 200,000, While Cases Start to Climb AgainCDC Reverses COVID Test Guideline After ControversyAs Schools Reopen, Many Students, Staff Live With High-Risk Family MemberCOVID-19 Poses Added Risk for People With Addiction Disorders: StudyGetting a Hip Replacement? Choice of Hospital Can Be CrucialAlmost 90,000 Young American Adults Will Get Cancer This Year: ReportAnother Rapid COVID-19 Test Shows PromiseDetails Emerge on Unexplained Illness in AstraZeneca COVID Vaccine TrialRising Obesity Levels Put Americans at Risk During Pandemic: CDCMore Pets May Be Getting COVID-19 Than RealizedWildfire Smoke Poses Special Threat to People With AsthmaCOVID-19 Prevention Might Translate Into Record Low Flu Rates: CDCFor Stroke Survivors, Timely Rehab Has Been Jeopardized During PandemicCOVID-19 Has Taken a Toll on Organ DonationCOVID Conflicts Are Putting Big Strains on RelationshipsCoronavirus Vaccine Plan for Americans AnnouncedParkinson's Ups the Odds for Dangerous Falls, But Prevention Is KeyPregnant Women With COVID-19 at High Risk for ComplicationsCompanion Drug Might Help Prevent Kidney Complications of LupusAHA News: Making Sense of Cholesterol – the Good, the Bad and the DietaryDo Ordinary Eyeglasses Offer Protection Against COVID-19?Elevated Blood Clotting Factor Linked to Worse COVID-19 OutcomesParkinson's Drug Eyed as Treatment for Severe Macular Degeneration
Questions and AnswersLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Could the MMR Vaccine Help Prevent COVID-19? New Trial May Tell

HealthDay News
by -- Steven Reinberg
Updated: Sep 4th 2020

new article illustration

FRIDAY, Sept. 4, 2020 (HealthDay News) -- A new clinical trial will try to determine whether the measles, mumps and rubella (MMR) vaccine can protect health care workers from being infected with COVID-19.

Hundreds of millions of people have received the MMR vaccine since it was developed nearly 50 years ago. It's usually given to children before age 6. Growing evidence suggests that the vaccine may also prevent COVID-19.

"We know that the MMR vaccine is safe, and we think there are two main reasons that it could prevent COVID-19," said researcher Dr. Michael Avidan, head of the department of anesthesiology at Washington University School of Medicine in St. Louis.

"The first is this vaccine includes small amounts of live but very weakened measles, mumps and rubella viruses," Avidan explained in a university news release. "This type of vaccine appears to strengthen the body's immune response to infections in general, not just to the viruses in that particular vaccine."

The MMR vaccine may also work because it protects against viruses that are similar to coronavirus. The researchers think that antibodies made to the MMR vaccine might also fight SARS-CoV-2 (the virus that causes COVID-19).

In addition, the researchers hope that the MMR vaccine might make cases of COVID-19 milder.

The trial is funded by a $9 million grant from the Bill and Melinda Gates Foundation, Wellcome Trust, Mastercard, and other public and philanthropic donors.

Researchers hope to enroll as many as 30,000 health care workers around the world. Participants will be randomly selected to get the MMR vaccine or a placebo.

Most of those recruited for the trial will receive a booster, as they likely received the vaccine as children. But in some countries where the MMR vaccine isn't widely given, health care workers may be receiving the vaccine for the first time, the researchers noted.

The countries involved in the study include Canada, Ghana, Ireland, South Africa, Uganda, United Kingdom, United States, Zambia and Zimbabwe.

Each study participant will be followed for five months, and the entire trial is expected to last about a year, the researchers said. Scientists at University College London (UCL) will compile the data from the trial.

"If we discover that the MMR vaccine can help train the body's immune response to SARS-CoV-2 infection, then we will have something to administer very quickly, while waiting for more specific vaccines and preventive therapies to be developed," explained researcher Dr. Laurence Lovat, a professor of gastroenterology and biophotonics at UCL.

"If the trial shows that the MMR vaccine can boost the body's general immune response, we believe it may enhance the effectiveness of vaccines currently in development to prevent SARS-CoV-2 infection," he added.

More information

For more on COVID-19, head to the U.S. Centers for Disease Control and Prevention.